Home » Topics » Conferences

Conferences
RSS

New selective estrogen receptor modulator from Lilly

April 22, 1997

Balanced ETA/ETB antagonist from Abbott

April 22, 1997

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Orally bioavailable cyclic HIV protease inhibitors with low potential for drug resistance

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...